Last reviewed · How we verify
NCT05822492
Anterior Quadratus Lumborum Block Versus Erector Spina Plane Block in Percutaneous Nephrolithotomy Surgery
trial testing Group QLB3 in Anesthesia in 90 participants. Completed in 30 September 2023.
20 September 2023
Quick facts
| Lead sponsor | Ondokuz Mayıs University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 20 April 2023 |
| Primary completion | 20 September 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Group QLB3
- Group ESPB
- Group Control
Conditions studied
- Anesthesia — all drugs for Anesthesia →
- Analgesia — all drugs for Analgesia →
- Patient Controlled Analgesia — all drugs for Patient Controlled Analgesia →
- Quadratus Lumborum Block — all drugs for Quadratus Lumborum Block →
Sponsor
Ondokuz Mayıs University
Who can join
Adults 18 to 65, any sex, with Anesthesia or Analgesia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, it was aimed to evaluate the effects of anterior quadratus lumborum block (QLB3) and Erector Spina Plane Block (ESPB) on postoperative acute pain scores and opioid consumption in the first 24 hours in Percutaneous Nephrolithotomy Surgery
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of anterior quadratus lumborum block versus erector spinae plane block on postoperative acute pain in percutaneous nephrolithotomy: a prospective, observational study.
Turkan H, Kaya C, Turunc E, Dost B, et al · · 2024 · cited 1× · PMID 39256675 · DOI 10.1186/s12871-024-02691-7
Verify or expand the search:
- PubMed search for NCT05822492
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anesthesia
Currently open trials in the same condition.
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
- NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
- NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting
Other Ondokuz Mayıs University trials
Trials by the same sponsor.
- NCT07500389 — Postural Habits, Body Awareness, and Functional Performance Across BMI Categories in Women · not yet recruiting
- NCT07535242 — Serum GFAP, NfL, VEGF and Clinical Progression in Progressive MS · not yet recruiting
- NCT07504848 — Stroke Mobility and Caregiver Outcomes · not yet recruiting
- NCT07525557 — Kinesiophobia, Pain and Disability in Chronic Neck Pain · recruiting
- NCT07497802 — Mindfulness-Based Psychoeducation for Women With Gynecological Cancer · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05822492 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ondokuz Mayıs University
- Last refreshed: 8 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05822492.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing